AI assistant
Sending…
Compugen Ltd. — Report Publication Announcement 2016
Dec 7, 2016
6734_rns_2016-12-07_0ecff07b-2e9a-41a1-bed1-c6694cdc9412.htm
Report Publication Announcement
Open in viewerOpens in your device viewer
_________ false
| �������� ��"� | 2 380 |
| COMPUGEN LTD | |
| Corporation no: 511779639 | 10690 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C002 ( Public ) | Reported via MAGNA: | 07/12/2016 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2016-02-086691 | Time of broadcast: 13:56 13:38:58 |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
| Attached hereto is a report on Compugen Discloses its Cancer Immunotherapy Program Targeting TIGIT Immune Checkpoint |
| a1619285_isa.pdf |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: TASE | Date of revision of form structure: 31/10/2016 |
| Address: Pinchas Rosen 72 , Tel Aviv 69512 , Tel: 03-7658585 , 03-7658525 Fax: 03-7658555 | |
| E-mail address: [email protected] | |
| Previous names of reporting entity: | |
| Name of the Signatory: Gershowitz Donna Lynn Position of Signatory in the reporting corporation: General Counsel Name of Employer Company: | |
| Address: Harokmim Street 26 , Holon 5885849 Telephone: 03-7658585 Facsimile: 03-7658555 E-mail: [email protected] 1 | |
More from Compugen Ltd.
Capital/Financing Update
2026
May 18
Report Publication Announcement
2026
May 18
Earnings Release
2026
May 18
Report Publication Announcement
2026
May 18
Regulatory Filings
2026
May 12
Report Publication Announcement
2026
May 12
Report Publication Announcement
2026
May 4
Report Publication Announcement
2026
May 4
Director's Dealing
2026
Apr 27
Director's Dealing
2026
Apr 27